The alternative pathway of complement activation is longitudinally associated with obesity: the CODAM study

被引:0
|
作者
Xin, Y.
Hertle, E.
van der Kallen, C.
Schalkwijk, C.
Stehouwer, C.
van Greevenbroek, M.
机构
[1] Maastricht Univ, Med Ctr, Internal Med, Masstricht, Netherlands
[2] Cardiovasc Res Inst, Masstricht, Netherlands
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
618
引用
收藏
页码:S293 / S294
页数:2
相关论文
共 50 条
  • [1] The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes The CODAM study
    Hertle, Elisabeth
    Arts, Ilja C. W.
    van der Kallen, Carla J. H.
    Feskens, Edith J. M.
    Schalkwijk, Casper G.
    Stehouwer, Coen D. A.
    van Greevenbroek, Marleen M. J.
    THROMBOSIS AND HAEMOSTASIS, 2016, 115 (02) : 446 - 457
  • [2] Activation of the alternative pathway of complement, represented by factor Bb, is longitudinally associated with beta cell conservation in type 2 diabetes: the CODAM study
    van Greevenbroek, M. M. J.
    Xin, Y.
    Schuitemaker, T.
    van derKallen, C. J. H.
    Hertle, E.
    Schalkwijk, C. G.
    Stehouwer, C. D. A.
    DIABETOLOGIA, 2016, 59 : S73 - S74
  • [3] Activation of the alternative pathway of complement, represented by factor Bb, is longitudinally associated with late β-cell conservation in type 2 diabetes: The CODAM study
    van Greevenbroek, Marleen
    Xin, Ying
    Schuitemaker, Thomas
    van der Kallen, Carla
    Hertle, Elisabeth
    Schalkwijk, Casper
    Stehouwer, Coen
    MOLECULAR IMMUNOLOGY, 2017, 89 : 189 - 189
  • [4] THE ALTERNATIVE COMPLEMENT PATHWAY IS ASSOCIATED WITH AN ADVERSE LIPID PROFILE: THE CODAM STUDY
    Xin, Y.
    van der Kallen, C. J. H.
    Schalkwijk, C. G.
    Stehouwer, C. D. A.
    van Greevenbroek, M. M. J.
    ATHEROSCLEROSIS, 2019, 287 : E30 - E31
  • [5] The alternative complement pathway is associated with an adverse lipid profile: the CODAM study
    Jin, S.
    Xin, Y.
    van der Kallen, C.
    Vogelzangs, N.
    Arts, I.
    Schalkwijk, C.
    Stehouwer, C.
    van Greevenbroek, M.
    DIABETOLOGIA, 2019, 62 : S294 - S294
  • [6] Association of the alternative pathway of complement activation with incident cardiovascular diseases: the CODAM study
    Hertle, Elisabeth
    Arts, Ilja C. W.
    van der Kallen, Carla J. H.
    Feskens, Edith J. M.
    Schalkwijk, Casper G.
    Stehouwer, Coen D. A.
    van Greevenbroek, Marleen M. J.
    MOLECULAR IMMUNOLOGY, 2014, 61 (02) : 228 - 228
  • [7] Association of the alternative pathway of complement activation with incident cardiovascular diseases: the CODAM study
    Hertle, E.
    Arts, I. C. W.
    van der Kallen, C. J. H.
    Feskens, E. J. M.
    Schalkwijk, C. G.
    Stehouwer, C. D. A.
    van Greevenbroek, M. M. J.
    DIABETOLOGIA, 2014, 57 : S502 - S502
  • [8] Associations of the alternative pathway and classical pathway of complement activation with incident metabolic syndrome: The CODAM study
    Xin, Ying
    Hertle, Elisabeth
    van der Kallen, Carla J. H.
    Schalkwijk, Casper G.
    Stehouwer, Coen D. A.
    van Greevenbroek, Marleen M. J.
    MOLECULAR IMMUNOLOGY, 2017, 89 : 190 - 190
  • [9] Longitudinal associations of the alternative and terminal pathways of complement activation with adiposity: The CODAM study
    Xin, Ying
    Hertle, Elisabeth
    van der Kallen, Carla J. H.
    Schalkwijk, Casper G.
    Stehouwer, Coen D. A.
    van Greevenbroek, Marleen M. J.
    OBESITY RESEARCH & CLINICAL PRACTICE, 2018, 12 (03) : 286 - 292
  • [10] ASSOCIATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT ACTIVATION WITH INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND CAROTID INTIMA-MEDIA THICKNESS: THE CODAM STUDY
    Hertle, E.
    Arts, I. C. W.
    van der Kallen, C. J. H.
    Feskens, E. J. M.
    Schalkwijk, C. G.
    Stehouwer, C. D. A.
    van Greevenbroek, M. M. J.
    ATHEROSCLEROSIS, 2015, 241 (01) : E67 - E67